Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola Vaccines”

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05301504
What this trial is testing

A Study in Tanzania of a New Vaccine Against Two Types of Ebola

Who this might be right for
Ebola
University of Oxford 76
Early research (Phase 1)Study completedNCT02283099
What this trial is testing

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)

Who this might be right for
Hemorrhagic Fever, Ebola
Universitätsklinikum Hamburg-Eppendorf 30
Large-scale testing (Phase 3)Looking for participantsNCT06126822
What this trial is testing

Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination with the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC

Who this might be right for
Ebola Virus Disease
Institute of Tropical Medicine, Belgium 624
Not applicableStudy completedNCT03820739
What this trial is testing

EBOVAC-Salone Extension

Who this might be right for
Ebola Virus Disease
London School of Hygiene and Tropical Medicine 653
Large-scale testing (Phase 3)Study completedNCT02543567
What this trial is testing

Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 525
Early research (Phase 1)Study completedNCT00072605
What this trial is testing

Experimental Ebola Vaccine Trial

Who this might be right for
Hemorrhagic Fever, EbolaHealthy
National Institute of Allergy and Infectious Diseases (NIAID) 27
Early research (Phase 1)Study completedNCT02401373
What this trial is testing

A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.

Who this might be right for
Ebola Virus Disease
First Affiliated Hospital of Zhejiang University 61
Large-scale testing (Phase 3)Study completedNCT02509494
What this trial is testing

Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo

Who this might be right for
Ebola Virus Disease
Janssen Vaccines & Prevention B.V. 1,023
Early research (Phase 1)Study completedNCT02485912
What this trial is testing

Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination

Who this might be right for
Ebola Virus Disease
University of Oxford 40
Early research (Phase 1)Study completedNCT05079750
What this trial is testing

A New Vaccine Against Two Types of Ebola

Who this might be right for
Ebola
University of Oxford 26
Early research (Phase 1)Study completedNCT02269423
What this trial is testing

Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)

Who this might be right for
Ebola Virus
Merck Sharp & Dohme LLC 39
Early research (Phase 1)Study completedNCT02313077
What this trial is testing

A Safety and Immunogenicity Study of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Crucell Holland BV 87
Large-scale testing (Phase 3)Study completedNCT02503202
What this trial is testing

Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012)

Who this might be right for
Prevention of Ebola Infection
Merck Sharp & Dohme LLC 1,197
Testing effectiveness (Phase 2)Study completedNCT06036602
What this trial is testing

Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults

Who this might be right for
Ebola Sudan Virus Disease
Albert B. Sabin Vaccine Institute 125
Early research (Phase 1)Study completedNCT02267109
What this trial is testing

Phase 1 Trial of Ebola Vaccine in Mali

Who this might be right for
Ebola Virus DiseaseHemorrhagic Fever
University of Maryland, Baltimore 91
Large-scale testing (Phase 3)Study completedNCT02378753
What this trial is testing

STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)

Who this might be right for
Hemorrhagic Fever, Ebola
Centers for Disease Control and Prevention 8,651
Early research (Phase 1)Study completedNCT02533791
What this trial is testing

A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization

Who this might be right for
Ebola Virus Disease
Jiangsu Province Centers for Disease Control and Prevention 110
Testing effectiveness (Phase 2)Study completedNCT02788227
What this trial is testing

Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV∆G-ZEBOV-GP Vaccine)

Who this might be right for
Healthy Volunteers
National Institutes of Health Clinical Center (CC) 248
Early research (Phase 1)Study completedNCT02231866
What this trial is testing

Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 143
Post-approval studies (Phase 4)UnknownNCT06587503
What this trial is testing

Safety and Immunogenicity of rVSVΔG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Booster Doses

Who this might be right for
Ebola Virus DiseaseCOVID-19
University of Birmingham 72
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation